SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001169245-20-000091
Filing Date
2020-11-12
Accepted
2020-11-12 16:19:44
Documents
63
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q phas-20200930.htm   iXBRL 10-Q 1519403
2 EX-31.1 ex311-phas10xq2020q3.htm EX-31.1 10209
3 EX-31.2 ex312-phas10xq2020q3.htm EX-31.2 10200
4 EX-32.1 ex-321xphas10xq2020q3.htm EX-32.1 4708
5 EX-32.2 ex-322xphas10xq2020q3.htm EX-32.2 4702
  Complete submission text file 0001169245-20-000091.txt   5573128

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT phas-20200930.xsd EX-101.SCH 43500
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT phas-20200930_cal.xml EX-101.CAL 64327
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT phas-20200930_def.xml EX-101.DEF 193967
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT phas-20200930_lab.xml EX-101.LAB 501645
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT phas-20200930_pre.xml EX-101.PRE 307335
11 EXTRACTED XBRL INSTANCE DOCUMENT phas-20200930_htm.xml XML 698281
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Filer) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38697 | Film No.: 201306996
SIC: 2834 Pharmaceutical Preparations